The use of transgenic mice in cancer and genome stability research

Sub-Cellular Biochemistry

Volumn 50, Issue , 2010, Pages 325-336

  Conmy, Sarah ^b   Nasheuer, Heinz Peter ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b NONE

Author keywords

Cancer; Genome stability; Transgenic mice

Indexed keywords

MUS; MUS MUSCULUS;

ANIMAL; EXPERIMENTAL NEOPLASM; GENETICS; GENOMIC INSTABILITY; MOUSE; REVIEW; TRANSGENIC MOUSE;

ANIMALS; GENOMIC INSTABILITY; MICE; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL;

EID: 77953010437     PISSN: 03060225     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-90-481-3471-7_17     Document Type: Article

References (34)

1. Atkin, N. B. (1986) Lack of reciprocal translocations in carcinomas. Cancer Genet Cytogenet, 21, 275–278.
2. Bartkova, J., Horejsi, Z., Koed, K., Kramer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., Orntoft, T., Lukas, J., and Bartkek, J. (2005) DNA damage response as a candidate anti-cancer barrier in early human tumourigenesis. Nature, 434, 864–870.
3. Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., Takaoka, M., Nakagawa, H., Tort, F., Fugger, K., Johanson, F., Sehested, M., Anderson, C. L., Dyrskjot, L., Arntoft, T., Lukas, J., Kittas, C., Helleday, T., Halazonetis, T. D., Bastek, J., and Gorgouli, V. G. (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature, 444, 633–637.
4. Blasco, M. A., Lee, H., Hande, M. P., Samper, E., Lansdorp, P. M., de Pinho, R. A., and Greide, C. W. (1997) Telomere shortening and tumour formation by mouse cells lacking telomerase RNA. Cell, 91, 25–34.
5. Blasco, M. A., Rizen, M., Greider, C. N., and Hanahan, D. (1996) Differential regulation of telomerase activity and telomerase RNA during multistage Tumourigenesis. Nat Genet, 12, 200–204.
6. Cahill, D. P., Kinzler, K. W., Vogelstein, K. B., and Lengauer, C. (1999) Genetic instability and Darwinian selection in tumours. Trends Cell Biol, 9, M57–M90.
7. Gonzalez-Suarez, E., Geserick, C., Flores, J. M., and Blasco, M. A. (2005) Antagonistic effects of telomerase on cancer and aging in K5-mTERT transgenic mice. Oncogene, 24, 2256–2270.
8. Gonzalez-Suarez, E., Samper, E., Flores, J. M., and Blasco, M. A. (2000) Telomerase-deficient mice with short telomeres are resistant to skin tumourigenesis. Nat Genet, 26, 114–117.
9. Gonzalez-Suarez, E., Samper, E., Ramirez, A., Flores, J. M., Martin-Caballero, J., Jorcano, J. L., and Blasco, M. A. (2001) Increased epidermal tumours and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mtert, in basal keratinocytes. EMBO J, 20, 2619–2630.
10. Gopinathan, A. and Tuveson, D. A. (2008) The use of GEM models for experimental cancer therapeutics. Dis Model Mech, 1, 83–86.
11. Gorgoulis, V. G., Vassiliou, L. F., Karakaidous, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., Ditullio, R. A., Kastrinakis, N. G., Levy, B., Kletsas, D., Yoneta, A., Hertyn, M., Kittas, C., and Halazonetis, T. D. (2005) Activation of the DNA damage checkpoint and genome instability in human precancerous lesions. Nature, 434, 907–913.
12. Hanahan, D. and Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumourigenesis. Cell, 86, 353–364.
13. Hanahan, D. and Weinberg, R. A. (2000) The hallmarks of cancer. Cell, 100, 57–70.
14. Hennighausen, L. (2000) Mouse models of breast cancer. Breast Cancer Res, 2, 2–7.
15. Heyer, J., Yang, K., Lipkin, M., Edelmann, W., and Kucherlapati, R. (1999) Mouse models of colorectal cancer. Oncogene, 18, 5325–5333
16. Hudson, W. A., Li, Q., Le, C., and Kersey, J. H. (1998) Xenotransplantation of human lym-phoid malignancies is optimised in mice with multiple immunological defects. Leukemia, 12, 2029–2033
17. Ittner, L. M. and Gotz, J. (2007) Pronuclear injection for the production of transgenic mice. Nat Protoc, 2, 1206–1215
18. Jonkers, J. and Berns, A. (2002) Conditional mouse models of sporadic cancer. Nature Rev Cancer, 2, 251–265
19. Joyner, A. L. (1993) Gene Targeting: A Practical Approach, Oxford University Press, Oxford, UK
20. Lengauer, C., Kinzler, K. W., and Vogelstein, B. (1998) Genetic instabilities in human cancers. Nature, 396, 643–649
21. Loeb, L. A. (1991) Mutator Phenotype may be required for multistage carcinogenesis. Cancer Res, 51, 3075–3079
22. Maser, R. S., Choudhury, B., Campbell, P. J., Feng, B., Wong, K., Protopopov, A., O’Neil, J., Gutierrez, A., Ivanova, E., Perna, I., Lin, E., Mani, V., Jiang, S., Weidemeyer, R., Kabbarah, O., Nogueira, C., Histen, G., Aster, J., Mansour, M., Duke, V., Foroni, L., Fielding, A. K., Goldstone, A. H., Rowe, J. M., Wang, Y. A., Look, A. T., Stratton, M. R., Chin, L., Futreal, P. A., and Depinho, R. A. (2007) Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature, 447, 966–971
23. Micco, D. I., Fumagalli, R., Cicalese, M., Piccinin, A., Dasparini, S., Luise, P., Schurra, C., Garre, C., Nuciforo, M., Bensimon, P. G., Maestro, A. R., Pelicci, P. G., and Di Fagagna, F. A. (2006) Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature, 444, 638–642
24. Moser, A. R., Pitot, H. C., and Dove, W. F. (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science, 247, 322–324
25. Nishisho, I., Nakamura, Y., Miyoshi, Y., Miki, Y., Ando, H., Horii, A., Koyama, K., Utsunomiya, J., Baba, S., and Hedge, P. (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science, 253, 665–669
26. O’Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88, 277–285
27. Prowse, K. R. and Greider, C. W. (1995) Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci USA, 92, 4818–4822
28. Richmond, A. and Yingjun, S. (2008) Mouse xenograft models vs. GEM models for human cancer therapeutics. Dis Model Mech, 1, 78–82
29. Sotillo, R., Hernando, E., Diaz-Rodriguez, E., Teruya-Feldstein, J., Cordon-Cardo, C., Lowe, S. W., and Benezra, R. (2007) Mad2 overexpression promotes aneuploidy and tumouri-genesis in mice. Cancer Cell, 11, 9–23
30. Su, L. K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A., and Dove, W. F. (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science, 265, 668–670
31. Twombly, R. (2002) First clinical trials of endostatin yield lukewarm Results. J Natl Cancer Inst, 94, 1520–1521
32. Wang, Y., Putnam, C. D., Kane, M. F., Zhang, W., Edelmann, L., Russell, R., Carrion, D. V., Chin, L., Kucherlapati, R., Kolodner, R. D., and Edelmann, W. (2005) Mutation in Rpa1 Results in defective DNA double-strand break repair, chromosomal instability and cancer in mice. Nat Genet, 37, 750–755
33. Xue, S., Gao, L., Hart, D., Gillmore, R., Qusim, W., Thrasher, A., Apperley, J., Engels, B., Uckert, W., Morris, E., and Stauss, H. (2005) Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene–transduced human T cells. Blood, 106, 3062–3067
34. Zhou, Z., Flesken-Nikitin, A., Corney, D. C., Wang, W., Goodrich, D. W., Roy-Burman, P., and Nikitin, A. Y. (2006) Synergy of p53 and Rb Deficiency in a conditional mouse model for metastatic prostate cancer. Cancer Res, 66, 7889–7898.